Scientific articles 10 Oct 2026 Rethinking Clinical Trial Design to Accelerate Therapeutics for Arboviral Epidemics Open Forum Infectious Diseases
News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Scientific articles 9 Oct 2026 A Perspective on Biomarkers, Candidates for Surrogate End Points to Accelerate Successful Development of New Antiparasitic Agents for the Treatment of Chronic Chagas Disease ACS Infectious Diseases
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 22 Sep 2026 Efficacy and safety of alternative benznidazole and nifurtimox regimens for adults with chronic Trypanosoma cruzi infection (TESEO): an open-label, randomised, non-inferiority phase 2b trial The Lancet Infection Diseases
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Scientific articles 1 Sep 2026 Analysis of the therapeutic gap for Trypanosoma cruzi infection in Colombia (2012 – 2022) Memórias do Instituto Oswaldo Cruz
Scientific articles 23 Apr 2020 Role of asymptomatic and symptomatic humans as reservoirs of visceral leishmaniasis in a Mediterranean context PLOS Neglected Tropical Diseases 2020
Scientific articles 23 Apr 2020 Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus PLOS Neglected Tropical Diseases
Scientific articles 17 Apr 2020 Chagas disease and healthcare rights in the Bolivian immigrant community of São Paulo, Brazil Tropical Medicine Infectious Diseases
Scientific articles 15 Apr 2020 Efficacy and safety assessment of different dosage of benznidazole for the treatment of Chagas disease in chronic phase in adults (MULTIBENZ study): study protocol for a multicenter randomized Phase II non-inferiority clinical trial expert consensus Trials
Scientific articles 2 Apr 2020 Global coalition to accelerate COVID-19 clinical research in resource-limited settings The Lancet
Scientific articles 1 Apr 2020 Latest advances in control of sleeping sickness: Towards elimination Bulletin of the Netherlands Society for Tropical Medicine and International Health
Scientific articles 1 Apr 2020 Onchocerciasis elimination: What’s left to do? Bulletin of the Netherlands Society for Tropical Medicine and International Health
Scientific articles 1 Apr 2020 Visceral leishmaniasis: Towards control Bulletin of the Netherlands Society for Tropical Medicine and International Health
Scientific articles 30 Mar 2020 Report of the fifth post-kala-azar dermal leishmaniasis consortium meeting, Colombo, Sri Lanka, 14–16 May 2018 Parasites Vectors
Scientific articles 29 Mar 2020 How clinical research can contribute to strengthening health systems in low resource countries Tropical Medicine and Infectious Diseases
Scientific articles 18 Mar 2020 Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases Seminars in Immunopathology
Scientific articles 12 Mar 2020 Rifampicin and clarithromycin (extended release) versus rifampicin and streptomycin for limited Buruli ulcer lesions: a randomised, open-label, non-inferiority phase 3 trial The Lancet
Scientific articles 29 Feb 2020 Time to embrace access programmes for medicines: Lessons from the South African flucytosine access programme International Journal of Infectious Diseases
Scientific articles 28 Feb 2020 CpG ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis PLOS Neglected Tropical Diseases
Scientific articles 24 Feb 2020 Patients’ preferences of cutaneous leishmaniasis treatment outcomes: Findings from an international qualitative study PLOS Neglected Tropical Diseases